Market revenue in 2023 | USD 294.0 million |
Market revenue in 2030 | USD 513.7 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 51.5% in 2023. Horizon Databook has segmented the India interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
The interventional cardiology devices market in India is growing due to increased demand for devices like stents and balloons used in procedures such as angioplasty, stenting, and Transcatheter Aortic Valve Replacement (TAVR).
In addition, according to a report published by NIH in December 2021, an estimated average of 1,500 interventional cardiologists operate within India's 4,185 Cardiac Catheterization Laboratories (CCL). This extensive network of skilled professionals and well-equipped facilities increases the demand for devices such as stents, balloons, and imaging technologies, driving market growth by facilitating a higher volume of procedures & treatments.
Furthermore, in a significant development aimed at enhancing accessibility and affordability of life-saving medical devices, the health ministry has announced the inclusion of coronary stents in the National List of Essential Medicines (NLEM), 2022. This move is expected to have a profound impact on the healthcare landscape in India, particularly in the field of interventional cardiology.
Horizon Databook provides a detailed overview of country-level data and insights on the India interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into India interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account